Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients

Cited by papers we hold 6

• The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment · 2021
  No notice
• Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion · 2020
  No notice
• Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells · 2018
  No notice
• Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects · 2018
  No notice
• Mitochondrial metabolism and cancer · 2017
  No notice
• Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.